Back to results
US 2021/0128699 A1Published application
Neutrophil activation regulator
AssigneesTobishi Pharmaceutical Co., Ltd., Tokai University Educational System
InventorsHaruchika MASUDA, Takayuki ASAHARA, Hirobumi SENGA
Life of this patent
Estimating the term…
Abstract
Provided are a neutrophil activation regulator and a therapeutic agent against diseases caused by neutrophil activation. A thrombin-like enzyme is used as an active ingredient of the neutrophil activation regulator and the therapeutic agent against diseases caused by neutrophil activation.
Claims10
A neutrophil activation regulator comprising a thrombin-like enzyme as an active ingredient.
Dependencies are inferred from the claim text.